Taltz (Ixekizumab)
Taltz (Ixekizumab)
Taltz (Ixekizumab) is a prescription biologic medication designed to treat moderate-to-severe plaque psoriasis, active psoriatic arthritis, and active ankylosing spondylitis. It works by targeting a specific protein in the body (IL-17A) that contributes to inflammation, helping to reduce symptoms and improve skin and joint health. Taltz is administered via subcutaneous injection and is often recommended for patients who have not responded well to traditional therapies.
Why Choose Taltz (Ixekizumab)?
- Helps clear skin in patients with moderate-to-severe plaque psoriasis
- Reduces joint pain, stiffness, and swelling in psoriatic arthritis
- Improves mobility and reduces symptoms in ankylosing spondylitis
- Quick onset of relief in many patients, often within 1–2 weeks
- Administered just once a month after initial loading doses
How to Use Taltz (Ixekizumab)?
- Always follow your doctor’s dosing schedule and instructions
- Wash your hands and ensure the injection site is clean
- Inject Taltz into the thigh, abdomen, or upper arm (avoid tender or bruised areas)
- Use a new syringe or autoinjector for each dose
- Store Taltz in the refrigerator; do not freeze
- Allow the pen to reach room temperature before use (around 30 minutes)
- Do not shake the medication
- Safely dispose of used syringes in a sharps container
Important Safety Information about Taltz
- Not suitable for individuals with a known allergy to ixekizumab or any of its components
- Taltz may increase the risk of infections, including upper respiratory or fungal infections
- Inform your doctor if you have tuberculosis (TB), Crohn’s disease, or other chronic infections
- Live vaccines should be avoided during treatment
- Discuss with your doctor if you are pregnant, planning to become pregnant, or breastfeeding
- Regular monitoring may be required while using Taltz
Fact Table
| Facts | Details |
| Brand Name | Taltz |
| Generic Name | Ixekizumab |
| Drug Class | Interleukin-17A (IL-17A) inhibitor |
| Used For | Plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, axial spondyloarthritis |
| Formulation | Subcutaneous injection |
| Dosage Strength | 80 mg/mL (prefilled syringe or autoinjector) |
| Initial Dose | Varies by condition; usually starts with a loading dose |
| Maintenance Dose | Typically 80 mg every 4 weeks after initial doses |
| How It Works | Blocks IL-17A, a protein that causes inflammation in autoimmune diseases |
| Onset of Action | Noticeable improvement typically seen within 1–2 weeks |
| Administration | Self-injected under the skin (subcutaneous) |
| Storage | Refrigerate at 2°C to 8°C (36°F to 46°F); do not freeze |
| Common Side Effects | Injection site reactions, upper respiratory infections, nausea |
| Not Recommended For | Individuals with active serious infections without medical supervision |
| Prescription Required | Yes |
Common Side Effects
Like all medications, Taltz (Ixekizumab) can cause side effects, although not everybody gets them. Understanding these side effects can help you use this medication safely and effectively.
- Injection site reactions (redness, itching, swelling)
- Upper respiratory infections (cold, sinus infection)
- Nausea
- Fungal infections (such as athlete’s foot or yeast infections)
- Headache
If you experience any side effects, discuss them with your healthcare provider. They can offer advice and may adjust your treatment if necessary. Report any severe or unexpected side effects immediately.
How Can You Buy Taltz (Ixekizumab)?
You can order Taltz (Ixekizumab) using these methods on our website:
- Order Online
- Order by Phone
- Order by Fax
- Order your refills
Visit our How to order page.
